Iovance Biotherapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.46

-0.09 (-2.54%)

As of May 9, 1:38 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 76%

Hold 4 24%

Sell 0 0%

Price Target

Analyst Price Target +1,482.9% upside

Low Target $41.45

Average Target $54.77

High Target $77.23

Current Price $3.46

Current
$3.46

Target
$54.77

$41.45 $54.77 avg $77.23

Scenario Analysis

Bear Case

$41.45

1,098.0%

Low target

Base Case

$54.77

+1,482.9%

Avg target

Bull Case

$77.23

+2,132.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$5.63

-38.5% from high

52-Week Low

$1.64

+111.2% from low

Target vs 52W High

$54.77

+872.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%